Register to chat with like-minded investors on our interactive forums.

Get Started

CVTX CV Therapeutics (MM)

20.01

0.00 (0.00%)

Jul 11 2024 - Closed

Delayed by 15 minutes

Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder

- Clinical evidence for unique Ranexa(R) mechanism of action - CHICAGO, March 31 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (NASDAQ:CVTX) announced today that ranolazine significantly (p

CV Therapeutics (NASDAQ:CVTX)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more CV Therapeutics Charts.

CV Therapeutics (NASDAQ:CVTX)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more CV Therapeutics Charts.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Share on Facebook Share on Twitter Share on Email

Loading Messages....

See More Message Board Posts

CV Therapeutics (MM) News

More CV Therapeutics (MM) News Articles

FBEC Worldwide (CE)

Movement Industries (PK)

ERHC Energy (CE)

Elite Pharmaceuticals (QB)

Decentral Life (PK)

Kraig Biocraft Laborator... (QB)

Anavex Life Sciences

Voip Pal Com (QB)

Asia Broadband (PK)

Fannie Mae (QB)

Good Vibrations Shoes (PK)

Bioelectronics (PK)

Delayed Upgrade Clock